Qlaira filmom obložene tablete
| Name | Qlaira filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-182628999 |
| Active Substance | estradiolvalerat dienogest |
| Composition | 1 tamnožuta tableta sadržava 3 mg estradiolvalerata, 1 srednjecrvena tableta sadržava 2 mg estradiolvalerata i 2 mg dienogesta, 1 svijetložuta tableta sadržava 2 mg estradiolvalerata i 3 mg dienogesta, 1 tamnocrvena tableta sadržava 1 mg estradiolvalerata, 1 bijela tableta ne sadržava djelatnu tvar |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Bayer Weimar GmbH und Co. KG., Weimar, Njemačka Bayer AG, Berlin, Njemačka |
| Marketing Authorisation Holder | Bayer d.o.o., Radnička cesta 80, Zagreb, Hrvatska |
| Marketing Authorisation Date | 15.02.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/850 |
| Registration Number | 381-12-01/30-18-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G03AB08 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Lista provjere za liječnike (verzija 1) Popratno pismo za liječnike Popratno pismo za ljekarnike |
| Educational materials for patients / caregivers |
Važne informacije za korisnicu (verzija 1) |
